Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 1446 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Achondrogenesis, Type II / Hypochondrogenesis | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Alternate Names | ||||||||||||||||||||||||||||||
| ACG2; ACG1B | ||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
Achondrogenesis, type II (ACG2; MIM 200610) and Hypochondrogenesis (MIM 200610) are lethal conditions caused by defects in COL2A1. Although they share phenotypic characteristics, ACG2 is considered more severe. Affected fetuses and infants have a large head, soft cranium, flat face, barrel shaped trunk, and short long bones. In ACG2 the entire spine and sacrum may not be ossified. Hydrops fetalis, prematurity and death at or shortly following birth is typical of both disorders. Achondrogenesis, type IB (ACG1B; MIM 600972) phenotypically resembles ACG2 but is caused by defects in the diastrophic sulfate transporter (DTDST). In ACG1B the head is normal or near normal in size and the thorax is thin. |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| COL2A1 | ||||||||||||||||||||||||||||||
| MIM | ||||||||||||||||||||||||||||||
| 200610 | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.